CoChat

Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance

Griffiths, R. R., Richards, W. A., McCann, U., Jesse, R. · 2006 · Psychopharmacology

The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.

Abstract

Rationale Although psilocybin has been used for centuries for religious purposes, little is known scientifically about its acute and persisting effects. Objectives This double-blind study evaluated the acute and longer-term psychological effects of a high dose of psilocybin relative to a comparison compound administered under comfortable, supportive conditions. Materials and methods The participants were hallucinogen-naïve adults reporting regular participation in religious or spiritual activities. Two or three sessions were conducted at 2-month intervals. Thirty volunteers received orally administered psilocybin (30 mg/70 kg) and methylphenidate hydrochloride (40 mg/70 kg) in counterbalanced order. To obscure the study design, six additional volunteers received methylphenidate in the first two sessions and unblinded psilocybin in a third session. The 8-h sessions were conducted individually. Volunteers were encouraged to close their eyes and direct their attention inward. Study monitors rated volunteers' behavior during sessions. Volunteers completed questionnaires assessing drug effects and mystical experience immediately after and 2 months after sessions. Community observers rated changes in the volunteer's attitudes and behavior. Results Psilocybin produced a range of acute perceptual changes, subjective experiences, and labile moods including anxiety. Psilocybin also increased measures of mystical experience. At 2 months, the volunteers rated the psilocybin experience as…

Overview

Integrity signals

Registry

Crossref · 10.1007/s00213-006-0457-5

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 53 references

Research works printed but not linked: 8

  1. Griffiths RR, Bigelow GE, Henningfield JE (1980) Similarities in animal and human drug-taking behavior. In: Mello NK (ed) Advances in substance abuse, vol 1. JAI, Greenwich, pp 1–90
  2. Metzner R (2004) Teonanacatl: sacred mushroom of visions. Four Tree, El Verano, CA
  3. Metzner R, Litwin G, Weil G (1965) The relation of expectation and mood to psilocybin reactions: a questionnaire study. Psychedelic Rev 5:3–39
  4. National Institute on Drug Abuse (2005) LSD NIDA infofacts. National Institute on Drug Abuse, Rockville, MD, February 2005
  5. Pahnke W (1963) Drugs and mysticism: an analysis of the relationship between psychedelic drugs and the mystical consciousness. Ph.D. thesis, Harvard University
  6. Presti DE, Nichols DE (2004) Biochemistry and neuropharmacology of psilocybin mushrooms. In: Metzner R, Darling DC (eds) Teonanacatl. Four Trees, El Verano, CA, pp 89–108
  7. Richards WA (1975) Counseling, peak experiences and the human encounter with death: an empirical study of the efficacy of DPT-assisted counseling in enhancing the quality of life of persons with terminal cancer and their closest family members. Ph.D. thesis, Catholic University of America, Washington, DC
  8. Stolaroff MJ (2001) A protocol for a sacramental service. In: Roberts TB (ed) Psychoactive sacramentals: essays on entheogens and religion. Council on Spiritual Practices, San Francisco, CA

Cited by

See all 1,684

Metadata

Authors
Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R.
Affiliations
Johns Hopkins University (US)
Corresponding author
Griffiths, R. R.
Venue
Psychopharmacology
Published
2006-07-07
Volume
187
Issue
3
Pages
268-283
ISSN
  • 0033-3158 (ISSN-L)
  • 1432-2072
OpenAlex
W2121441663
Cited by
1,684
References
54
Citations by year
2026: 111 · 2025: 214 · 2024: 202 · 2023: 189 · 2022: 168 · 2021: 150 · 2020: 100 · 2019: 74 · 2018: 70 · 2017: 66 · 2016: 64 · 2015: 37 · 2014: 45 · 2013: 34 · 2012: 46
FWCI
25.48
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute on Drug Abuse (R01DA003889, R01DA03889)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
  • Social Sciences › Health › Religion, Spirituality, and Psychology
  • Social Sciences › Psychology › Social Psychology › Paranormal Experiences and Beliefs
Keywords
psilocybin, mystical experience, spiritual meaning, personal meaning, long-term psychological effects, attitude and behavior change
MeSH terms
Adult, Affect, Blood Pressure, Double-Blind Method, Female, Hallucinogens, Heart Rate, Humans, Lysergic Acid Diethylamide, Male, Psilocybin, Surveys and Questionnaires, Cross-Over Studies, Substance-Related Disorders, Spirituality

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. https://app.cochat.ai/papers/10.1007/s00213-006-0457-5
The paper
Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006). Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology. https://doi.org/10.1007/s00213-006-0457-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.